Ongoing inflammatory conditions can affect B12 status
Sept 13: The FDA accepted for review Takedas Biologics License Application for a subcutaneous (SC) formulation of Entyvio for moderately to severely active Crohns disease following induction therapy with intravenous Entyvio
Daytime Protection Products GHK-Cu offers impressive protective benefits in daytime skincare products, such as day creams and sunscreens
Delivered by licensed medical professionals, our injections provide rapid absorption, personalized care, and mobile convenience, allowing you to experience the benefits wherever you are
As a methylcobalamin injection, it supports nerve health by repairing and maintaining nerve cells, relieving tingling, numbness, and other nerve-related issues
The FDA withdrew several compounded peptides from pharmacy dispensing in early 2024, including BPC-157 and TB-500, citing lack of approved drug application status